androgen suppression

Related by string. * androgens . Androgens . Androgen : androgen receptor impedes . androgen insensitivity syndrome . asymptomatic metastatic androgen . Androgen Insensitivity Syndrome . androgen insensitivity / suppressions . Suppression : wildfire suppression . ruthless suppression . bone marrow suppression . bloody suppression . Wildland Fire Suppression * androgen suppression therapy *

Related by context. Frequent words. (Click for all words.) 76 androgen deprivation 70 EBRT 69 neoadjuvant 68 chemoradiotherapy 68 biochemical recurrence 68 neoadjuvant chemotherapy 67 goserelin 67 warfarin therapy 67 chemoradiation 66 mg kg dose 66 adjuvant therapy 66 mycophenolate mofetil 66 cystectomy 66 mitoxantrone 65 ziprasidone 65 thromboembolic events 65 tumor resection 65 cerebrovascular events 65 univariate analysis 65 lipid lowering therapy 64 tamoxifen therapy 64 virologic failure 64 fibrinolysis 64 Natalizumab 64 serum concentrations 64 neoadjuvant therapy 63 serum PSA 63 DOXIL 63 cardiac toxicity 63 hepatotoxicity 63 XELOX 63 immunosuppressive agents 63 epirubicin 63 multivariate analyzes 63 androgen deprivation therapy 63 adalimumab 63 fluorouracil 63 FOLFIRI 63 subgroup analyzes 63 bisphosphonate therapy 63 QTc interval 63 liver transplant recipients 63 sulfasalazine 62 contralateral breast cancer 62 colorectal adenomas 62 % CI #.#-#.# [007] 62 median PFS 62 nephrectomy 62 lymph node involvement 62 xenograft models 62 fulvestrant 62 peginterferon 62 platelet inhibition 62 dual antiplatelet therapy 62 univariate 62 decitabine 62 tamsulosin 62 RRMS patients 62 carboplatin paclitaxel 62 thromboembolism 62 P = .# 62 daunorubicin 62 renal dysfunction 62 exemestane 62 TURP 62 virologic response 62 gout flares 62 distant metastasis 61 nonadherence 61 systemic toxicity 61 tolvaptan 61 cabazitaxel 61 postoperative complications 61 chlorambucil 61 confidence interval #.#-#.# 61 nab paclitaxel 61 placebo controlled clinical 61 placebo controlled trials 61 ARIMIDEX 61 bone metastasis 61 distant metastases 61 PREZISTA r 61 patients evaluable 61 adjuvant chemotherapy 61 PCa 61 allogeneic stem cell 61 LUTS 61 hydroxychloroquine 61 pharmacodynamic effects 61 left ventricular dysfunction 61 cardiotoxicity 61 hypomagnesemia 61 octreotide 61 plus dexamethasone 61 mRCC 61 antiplatelet therapy 61 AZOR 61 HSCT 61 antidepressant therapy 60 azacitidine 60 intravesical

Back to home page